How did antibiotics transform global food production from 1935 to 2017?
Antibiotics spread into nearly every corner of food production from the mid 1930s onward, used to treat and prevent disease in animals, increase feed conversion, and preserve food, and that spread triggered decades of conflict over drug residues and antimicrobial resistance. This is a historical analysis published in Humanities and Social Sciences Communications, not a clinical trial. It reconstructs the origins, global proliferation, and international regulation of agricultural antibiotics from archival records.
The story of antibiotics in food production runs alongside their medical use but with different motivations. On farms, whaling and fishing fleets, in processing plants, and in aquaculture operations, antibiotics were used to control disease pressure, raise yields, and cut the labour previously spent caring for individual animals. Globally, agricultural antibiotic use likely exceeds human consumption.
This agricultural transformation connects to themes from the penicillin podcast about the broader impact of antibiotic discovery, showing how these medicines influenced not just human health but entire economic systems and food production on a global scale.
What the analysis shows:
- Scale: Global agricultural antibiotic use likely exceeds human consumption, and projections cited in the paper predict a 69% increase in global agricultural antibiotic use between 2010 and 2030, driven by growing meat consumption in middle and low income countries
- Growth promotion: Researchers at American Cyanamid’s Lederle Laboratories found that unextracted antibiotic residues in fermentation waste increased animals’ weight gains, and low dosed antibiotic growth promoters were also believed to protect against bacterial disease
- A regulatory patchwork: Antibiotic concerns did not develop evenly. By the early 1970s a global patchwork of different regulations had formed: some countries targeted residues in food and milk, some tackled resistance selection, and some did nothing at all
- Resistance consequences: New metagenomics research and cases like the global spread of colistin resistance from Chinese pigs are clarifying the threat posed by agricultural resistance selection, though agriculture’s overall contribution remains contested
The paper argues that policymakers need to remember the long history of regulatory failures that produced today’s antibiotic infrastructures, and that effective stewardship requires addressing the economic dependencies, notions of development, and fragmented cultural understandings of risk that drive global antibiotic consumption.
Dr. Kumar’s Take
The agricultural use of antibiotics is one of the most significant but underappreciated consequences of the antibiotic era. I treat infections in the hospital with drugs whose usefulness has been shaped, in part, by eighty years of decisions made on farms, in feed mills, and in agriculture ministries.
The part of this history I find most instructive is how early the warnings came. Experts had been warning about antibiotic hazards since the 1940s, and those warnings were often set aside because the immediate productivity benefits were obvious and the risk was abstract. That pattern, a concrete gain now against a diffuse harm later, is the same one I see in clinical decisions about antibiotics today. Knowing the harm is real has never been sufficient on its own to change behaviour.
Historical Context
Agricultural antibiotic use began in the late 1930s, not the 1940s. The synthetic sulphonamides came first: in 1935 the German manufacturer Bayer marketed prontosil, the first effective drug against gram positive infections, and prontosil and sulphapyridine were marketed for use in animals in Britain from 1938 onward. In 1940, gramicidin was used to treat a mass outbreak of mastitis, udder infection in cows, at New York’s World Exhibition. Precious penicillin supplies were tested against mastitis in both Britain and Denmark as early as 1943.
In 1948, Merck’s sulfaquinoxaline became the first antibiotic officially licensed for routine inclusion in poultry feeds, against coccidiosis. The growth promotion effect was announced in late 1949, and the new B12 and growth promoter feeds were officially licensed in 1951. In Europe, growth promoters were licensed for use without veterinary prescription in West Germany in 1951, Britain in 1953, the Netherlands in 1954, and France in 1955.
What the Research Shows
The analysis documents several key aspects of antibiotics’ transformation of food production:
Scale and Scope of Use Antibiotics diffused rapidly into nearly all areas of food production and processing, and this was initially viewed as a story of progress on both sides of the Iron Curtain. Use covered treatment, prevention, feed conversion, and food preservation.
Production Efficiency Gains Medicated feeds and water promised both to curb disease in concentrated animal populations and to raise productivity by reducing the expensive labour spent caring for individual animals. On farms, the boundaries between growth promotion, therapy, and prophylaxis soon blurred.
Global Adoption Patterns The same substances were used in the Midwest, Yugoslavia, and Japan, but national and regional patterns of use varied substantially, as did perceptions of risk. By the 1960s, industrialised animal production had become an important export of both capitalist and non capitalist systems.
Economic Transformation Average per capita global meat consumption totalled 24 kg in 1961 and 43 kg in 2014. Meat consumption rose faster than global population growth, and global animal production grew 4 to 5 fold since 1961.
Resistance Development From the mid 1950s onward, agricultural antibiotic use triggered increasing conflict about drug residues and antimicrobial resistance. The paper describes the resulting antibiotic infrastructure as destined to undermine itself.
Practical Takeaways
- The timeline is older than most people assume: Antibiotics entered food production in the late 1930s, alongside their arrival in human medicine, not afterward
- Non therapeutic use was a business decision: Industry scientists devised non human antibiotic applications as a source of revenue beyond a seemingly saturated human antibiotic market
- Economic and health interests conflict: In the vast majority of countries, antibiotic regulation remained subject to a risk benefit matrix that prioritised cheap and reliable protein over antibiotic stewardship
- Global coordination is needed: A regulatory patchwork formed by the early 1970s, fragmented further over the next three decades, and proved unable to curb either antibiotic use or resistance
Related Studies and Research
- Penicillin: The Accidental Discovery That Changed Medicine and Won a War
- Global Burden of Bacterial Antimicrobial Resistance
- 2019 Antibiotic Resistance Threats Report
- Penicillin’s Discovery and Antibiotic Resistance: Lessons for the Future
FAQs
When did antibiotics first enter food production?
In the late 1930s. Bayer marketed prontosil in 1935, and prontosil and sulphapyridine were marketed for animal use in Britain from 1938. Gramicidin treated a mass mastitis outbreak in 1940, and penicillin was tested against mastitis in Britain and Denmark by 1943.
How does agricultural antibiotic use compare with human medicine?
Globally, agricultural antibiotic use likely exceeds human consumption.
How did growth promoters come about?
Researchers at American Cyanamid’s Lederle Laboratories were investigating antibiotic fermentation waste as a cheaper source of vitamin B12 feed supplements and found that the unextracted antibiotic residues increased animals’ weight gains. The effect was announced in late 1949, and the feeds were licensed in 1951.
What regulatory challenges emerged from agricultural antibiotic use?
Different countries prioritised different risks, some targeting residues in food and milk, others targeting resistance selection, and others doing nothing. That produced a global patchwork of regulations by the early 1970s which fragmented further and failed to curb either use or resistance.
Is agricultural use still rising?
Use has plateaued or declined recently in the US and some European countries, though overall consumption there remains high. Projections cited in the paper predict a 69% increase in global agricultural antibiotic use between 2010 and 2030, driven by growing meat consumption in middle and low income countries.
Bottom Line
Antibiotics entered food production in the late 1930s and spread into nearly every part of it, used to treat and prevent disease, increase feed conversion, and preserve food. That spread was bound up with the industrialisation of global agriculture, rising meat consumption, and Cold War competition, and it produced a fragmented regulatory patchwork that has failed to curb either antibiotic use or resistance. The author argues that reform requires confronting the economic dependencies and cultural understandings of risk behind that history, and that high income countries, having pioneered and exported antibiotic dependent production since the 1940s, carry a moral responsibility for the consequences elsewhere.
